2801 - 2850 of 7939 Results
Title
Year
-
RESTRICTEDTitle: Repurposing existing therapeutics, its importance in oncology drug development: Kinases as a potential targetJournal Name: British Journal of Clinical PharmacologyPublisher: WileyVol: 88Issue #: 1Start Page: 64End Page: 74Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.1111/bcp.14964Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/bcp.14964Citation Count: 18
-
OPENTitle: A Survey of People With Parkinson’s and Their Carers: The Management of Pain in Parkinson’sJournal Name: Journal of Geriatric Psychiatry and NeurologyPublisher: SAGE PublicationsVol: 35Issue #: 4Start Page: 613End Page: 621Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1177/08919887211023592Best OA location URL: https://doi.org/10.1177/08919887211023592Citation Count: 8
-
OPENTitle: APOE genotype dependent molecular abnormalities in the cerebrovasculature of Alzheimer’s disease and age-matched non-demented brainsJournal Name: Molecular BrainPublisher: Springer Science and Business Media LLCVol: 14Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13041-021-00803-9Best OA location URL: https://molecularbrain.biomedcentral.com/counter/pdf/10.1186/s13041-021-00803-9Citation Count: 18
- Lewy Body Dementia Association’s Industry Advisory Council: proceedings of the second annual meeting2021OPENTitle: Lewy Body Dementia Association’s Industry Advisory Council: proceedings of the second annual meetingJournal Name: Alzheimer's Research & TherapyPublisher: Springer Science and Business Media LLCVol: 13Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13195-021-00868-7Best OA location URL: https://alzres.biomedcentral.com/counter/pdf/10.1186/s13195-021-00868-7Citation Count: 1
- Seed Amplification Assay to Diagnose Early Parkinson's and Predict Dopaminergic Deficit Progression2021OPENTitle: Seed Amplification Assay to Diagnose Early Parkinson's and Predict Dopaminergic Deficit ProgressionJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 10Start Page: 2444End Page: 2446Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-nd, cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/mds.28715Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8530949Citation Count: 31
-
RESTRICTEDTitle: Telemedicine and Deep brain stimulation - Current practices and recommendationsJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 89Issue #:Start Page: 199End Page: 205Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.07.001Citation Count: 22
-
RESTRICTEDTitle: Asymmetry at Disease Onset Is Not a Predictor of Parkinson’s Disease ProgressionJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 11Issue #: 4Start Page: 1689End Page: 1694Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.3233/jpd-202525Citation Count: 6
-
OPENTitle: Neither a Novel Tau Proteinopathy nor an Expansion of a Phenotype: Reappraising Clinicopathology-Based NosologyJournal Name: International Journal of Molecular SciencesPublisher: MDPI AGVol: 22Issue #: 14Start Page: 7292End Page: 7292Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/ijms22147292Best OA location URL: https://www.mdpi.com/1422-0067/22/14/7292/pdf?version=1626760200Citation Count: 7
-
OPENTitle: Parkinson’s Disease Motor Symptom Progression Slowed with Multisensory Dance Learning over 3-Years: A Preliminary Longitudinal InvestigationJournal Name: Brain SciencesPublisher: MDPI AGVol: 11Issue #: 7Start Page: 895End Page: 895Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/brainsci11070895Best OA location URL: https://www.mdpi.com/2076-3425/11/7/895/pdf?version=1625647210Citation Count: 19
-
OPENTitle: Predictive Value of Verbatim Parkinson’s Disease Patient-Reported Symptoms of Postural Instability and FallingJournal Name: Journal of Parkinson's DiseasePublisher: SAGE PublicationsVol: 11Issue #: 4Start Page: 1957End Page: 1964Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.3233/jpd-212636Best OA location URL: https://content.iospress.com:443/download/journal-of-parkinsons-disease/jpd212636?id=journal-of-parkinsons-disease%2Fjpd212636Citation Count: 11
-
OPENTitle: Prescribing Aducanumab in the Face of Meager Efficacy and Real RisksJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 97Issue #: 11Start Page: 545End Page: 547Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0000000000012452Best OA location URL: https://n.neurology.org/content/neurology/97/11/545.full.pdfCitation Count: 28
-
RESTRICTEDTitle: Strength of clinical evidence leading to approval of novel cancer medicines in Europe: A systematic review and data synthesisJournal Name: Pharmacology Research & PerspectivesPublisher: WileyVol: 9Issue #: 4Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1002/prp2.816Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8262606Citation Count: 1
-
OPENTitle: TOMM40 ‘523’ poly-T repeat length is a determinant of longitudinal cognitive decline in Parkinson’s diseaseJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 7Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-021-00200-yBest OA location URL: https://www.nature.com/articles/s41531-021-00200-y.pdfCitation Count: 4
-
OPENTitle: Understanding the effect of smoking and drinking behavior on Parkinson's disease risk: a Mendelian randomization studyJournal Name: Scientific ReportsPublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41598-021-93105-yBest OA location URL: https://www.nature.com/articles/s41598-021-93105-y.pdfCitation Count: 22
-
OPENTitle: Copy Number Variation in Parkinson's Disease: An Update from Sub‐Saharan AfricaJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 10Start Page: 2442End Page: 2444Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.28710Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8530875Citation Count: 3
-
RESTRICTEDTitle: Plant immune system activation is necessary for efficient interaction with auxin secreting beneficial bacteriaJournal Name:Publisher:Vol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.17632/8zyrz7ccbh.1Citation Count: 0
-
RESTRICTEDTitle: Diagnostic accuracy of narrow‐band imaging endoscopy with targeted biopsies compared with standard endoscopy with random biopsies in patients with Barrett's esophagus: A systematic review and meta‐analysisJournal Name: Journal of Gastroenterology and HepatologyPublisher: WileyVol: 36Issue #: 10Start Page: 2659End Page: 2671Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-ncDOI - Digital Object Identifier: 10.1111/jgh.15577Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/jgh.15577Citation Count: 15
-
RESTRICTEDTitle: MicroRNAs as Molecular Biomarkers for Parkinson's Disease ProgressionJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 8Start Page: 1793End Page: 1793Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28700Citation Count: 0
-
OPENTitle: They Look but Do Not See—Gaze‐Evoked Eyelid SpasmJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 8Issue #: 7Start Page: 1123End Page: 1125Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.13279Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.13279Citation Count: 0
-
RESTRICTEDTitle: Neuroinflammation and L-dopa-induced abnormal involuntary movements in 6-hydroxydopamine-lesioned rat model of Parkinson's disease are counteracted by combined administration of a 5-HT1A/1B receptor agonist and A2A receptor antagonistJournal Name: NeuropharmacologyPublisher: Elsevier BVVol: 196Issue #:Start Page: 108693End Page: 108693Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neuropharm.2021.108693Citation Count: 14
-
OPENTitle: Arousal characteristics in patients with Parkinson’s disease and isolated rapid eye movement sleep behavior disorderJournal Name: SleepPublisher: Oxford University Press (OUP)Vol: 44Issue #: 12Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/sleep/zsab167Best OA location URL: https://academic.oup.com/sleep/article-pdf/44/12/zsab167/41608831/zsab167.pdfCitation Count: 5
-
RESTRICTEDTitle: Elevated Mood States in Patients With Parkinson’s Disease Treated With Deep Brain Stimulation: Diagnosis and Management StrategiesJournal Name: The Journal of Neuropsychiatry and Clinical NeurosciencesPublisher: American Psychiatric Association PublishingVol: 33Issue #: 4Start Page: 314End Page: 320Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1176/appi.neuropsych.20080205Citation Count: 8
-
OPENTitle: Lifestyle Factors and Parkinson’s Disease Risk in a Rural New England Case-Control StudyJournal Name: Parkinson's DiseasePublisher: Hindawi LimitedVol: 2021Issue #:Start Page: 1End Page: 7Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1155/2021/5541760Best OA location URL: https://downloads.hindawi.com/journals/pd/2021/5541760.pdfCitation Count: 3
-
OPENTitle: SETD7-mediated monomethylation is enriched on soluble Tau in Alzheimer’s diseaseJournal Name: Molecular NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 16Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/s13024-021-00468-xBest OA location URL: https://molecularneurodegeneration.biomedcentral.com/counter/pdf/10.1186/s13024-021-00468-xCitation Count: 12
-
RESTRICTEDTitle: Advances in protein-protein interaction network analysis for Parkinson's diseaseJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 155Issue #:Start Page: 105395End Page: 105395Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.nbd.2021.105395Best OA location URL: https://doi.org/10.1016/j.nbd.2021.105395Citation Count: 31
-
OPENTitle: Altered conformation of α-synuclein drives dysfunction of synaptic vesicles in a synaptosomal model of Parkinson’s diseaseJournal Name: Cell ReportsPublisher: Elsevier BVVol: 36Issue #: 1Start Page: 109333End Page: 109333Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.celrep.2021.109333Best OA location URL: http://www.cell.com/article/S2211124721007099/pdfCitation Count: 28
-
RESTRICTEDTitle: Beyond Just Connectivity — Neuronal Activity Drives α‐Synuclein PathologyJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 7Start Page: 1487End Page: 1488Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/mds.28618Citation Count: 4
-
RESTRICTEDTitle: Coexistence of deep brain stimulators and cardiac implantable electronic devices: A systematic review of safetyJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 88Issue #:Start Page: 129End Page: 135Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.04.018Best OA location URL: https://scholarlypublications.universiteitleiden.nl/access/item%3A3638884/viewCitation Count: 2
-
OPENTitle: Effect of Esketamine Nasal Spray on Olfactory Function and Nasal Tolerability in Patients with Treatment-Resistant Depression: Results from Four Multicenter, Randomized, Double-Blind, Placebo-Controlled, Phase III StudiesJournal Name: CNS DrugsPublisher: Springer Science and Business Media LLCVol: 35Issue #: 7Start Page: 781End Page: 794Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1007/s40263-021-00826-9Best OA location URL: https://link.springer.com/content/pdf/10.1007/s40263-021-00826-9.pdfCitation Count: 12
-
OPENTitle: Genetic diversity of axon degenerative mechanisms in models of Parkinson's diseaseJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 155Issue #:Start Page: 105368End Page: 105368Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.nbd.2021.105368Best OA location URL: https://doi.org/10.1016/j.nbd.2021.105368Citation Count: 18
-
OPENTitle: Letter to the Editor: Randomized Trial of Botulinum Toxin Type A in Hereditary Spastic Paraplegia—The SPASTOX TrialJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 7Start Page: 1733End Page: 1733Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28659Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28659Citation Count: 1
-
OPENTitle: LRRK2 p.M1646T is associated with glucocerebrosidase activity and with Parkinson's diseaseJournal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 103Issue #:Start Page: 142.e1End Page: 142.e5Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2021.02.018Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8178224Citation Count: 16
-
RESTRICTEDTitle: Managing Advanced Parkinson DiseaseJournal Name: Journal of Geriatric Psychiatry and NeurologyPublisher: SAGE PublicationsVol: 34Issue #: 4Start Page: 289End Page: 300Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1177/08919887211018277Citation Count: 6
-
RESTRICTEDTitle: Parkinson disease-associated cognitive impairmentJournal Name: Nature Reviews Disease PrimersPublisher: Springer Science and Business Media LLCVol: 7Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1038/s41572-021-00280-3Best OA location URL: https://www.nature.com/articles/s41572-021-00280-3.pdfCitation Count: 392
-
RESTRICTEDTitle: Parkinson’s disease and cancer: a systematic review and meta-analysis of over 17 million participantsJournal Name: BMJ OpenPublisher: BMJVol: 11Issue #: 7Start Page: e046329End Page: e046329Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1136/bmjopen-2020-046329Best OA location URL: https://bmjopen.bmj.com/content/bmjopen/11/7/e046329.full.pdfCitation Count: 18
-
RESTRICTEDTitle: Progress towards therapies for disease modification in Parkinson's diseaseJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 20Issue #: 7Start Page: 559End Page: 572Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(21)00061-2Best OA location URL: https://discovery.ucl.ac.uk/10130306/1/Foltynie_Disease%20Modifying%20reviewVersion4_ML2_CLEAN.pdfCitation Count: 157
-
RESTRICTEDTitle: Should we start integrating genetic data in decision-making on device-aided therapies in Parkinson disease? A point of viewJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 88Issue #:Start Page: 51End Page: 57Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.05.013Citation Count: 16
-
OPENTitle: Comparison between four published definitions of hyposmia in Parkinson's diseaseJournal Name: Brain and BehaviorPublisher: WileyVol: 11Issue #: 8Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/brb3.2258Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/brb3.2258Citation Count: 5
-
OPENTitle: Correction: Data Sharing Goals for Nonprofit Funders of Clinical TrialsJournal Name: Journal of Participatory MedicinePublisher: JMIR Publications Inc.Vol: 13Issue #: 2Start Page: e31371End Page: e31371Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.2196/31371Best OA location URL: https://jopm.jmir.org/2021/2/e31371/PDFCitation Count: 0
-
OPENTitle: Genetics of Parkinson’s disease in the Polish populationJournal Name: Neurologia i Neurochirurgia PolskaPublisher: VM Media SP. zo.o VM Group SKVol: 55Issue #: 3Start Page: 241End Page: 252Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.5603/pjnns.a2021.0013Best OA location URL: https://journals.viamedica.pl/neurologia_neurochirurgia_polska/article/download/PJNNS.a2021.0013/54764Citation Count: 16
-
RESTRICTEDTitle: Moving towards Integrated and Personalized Care in Parkinson’s Disease: A Framework Proposal for Training Parkinson NursesJournal Name: Journal of Personalized MedicinePublisher: MDPI AGVol: 11Issue #: 7Start Page: 623End Page: 623Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3390/jpm11070623Best OA location URL: https://www.mdpi.com/2075-4426/11/7/623/pdf?version=1625207859Citation Count: 20
-
RESTRICTEDTitle: On demand therapy for Parkinson’s disease patients: Opportunities and choicesJournal Name: Postgraduate MedicinePublisher: Informa UK LimitedVol: 133Issue #: 7Start Page: 721End Page: 727Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1080/00325481.2021.1936087Best OA location URL: https://www.tandfonline.com/doi/pdf/10.1080/00325481.2021.1936087?needAccess=trueCitation Count: 16
- Solriamfetol for Excessive Daytime Sleepiness in Parkinson's Disease: Phase 2 Proof‐of‐Concept Trial2021OPENTitle: Solriamfetol for Excessive Daytime Sleepiness in Parkinson's Disease: Phase 2 Proof‐of‐Concept TrialJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 10Start Page: 2408End Page: 2412Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28702Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8596433Citation Count: 10
-
OPENTitle: Temporal Ordering of Inflammatory Analytes sTNFR2 and sTREM2 in Relation to Alzheimer's Disease Biomarkers and Clinical OutcomesJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 13Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2021.676744Best OA location URL: https://www.frontiersin.org/articles/10.3389/fnagi.2021.676744/pdfCitation Count: 11
- CSF Protein Level of Neurotransmitter Secretion, Synaptic Plasticity, and Autophagy in PD and DLB2021OPENTitle: CSF Protein Level of Neurotransmitter Secretion, Synaptic Plasticity, and Autophagy in PD and DLBJournal Name: Movement DisordersPublisher: WileyVol: 36Issue #: 11Start Page: 2595End Page: 2604Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28704Best OA location URL: https://discovery.ucl.ac.uk/10131553/1/mds.28704.pdfCitation Count: 19
-
OPENTitle: Directed Brain Connectivity Identifies Widespread Functional Network Abnormalities in Parkinson’s DiseaseJournal Name: Cerebral CortexPublisher: Oxford University Press (OUP)Vol: 32Issue #: 3Start Page: 593End Page: 607Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1093/cercor/bhab237Best OA location URL: https://academic.oup.com/cercor/article-pdf/32/3/593/42259699/bhab237.pdfCitation Count: 9
-
OPENTitle: High cerebrospinal amyloid-β 42 is associated with normal cognition in individuals with brain amyloidosisJournal Name: eClinicalMedicinePublisher: Elsevier BVVol: 38Issue #:Start Page: 100988End Page: 100988Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.eclinm.2021.100988Best OA location URL: http://www.thelancet.com/article/S2589537021002686/pdfCitation Count: 91
-
OPENTitle: Home Health Management of Parkinson Disease Deep Brain StimulationJournal Name: JAMA NeurologyPublisher: American Medical Association (AMA)Vol: 78Issue #: 8Start Page: 972End Page: 972Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1001/jamaneurol.2021.1910Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8240011Citation Count: 15
-
RESTRICTEDTitle: Too much for your own good: Excessive dopamine damages neurons and contributes to Parkinson's diseaseJournal Name: Journal of NeurochemistryPublisher: WileyVol: 158Issue #: 4Start Page: 833End Page: 836Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1111/jnc.15442Citation Count: 5
-
OPENTitle: White Matter Hyperintensities Are Associated With Severity of Essential Tremor in the ElderlyJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 12Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2021.694286Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2021.694286/pdfCitation Count: 7